Bariatric Endoscopy

According to a study published in Therapeutic Advances in Gastroenterology, internal endoscopic drainage should be the first line endoscopic treatment of anastomotic fistulas when possible.

Using Ozempic in combination with endoscopic sleeve gastrectomy resulted in greater weight loss than the procedure alone, according to a presentation at Digestive Diseases Week.

The American Gastroenterological Association published new clinical practice guidelines on the use of intragastric balloons in obesity management.

Patients with non-alcoholic fatty liver disease who underwent endoscopic bariatric and metabolic therapies saw improvements in liver fibrosis and other outcomes, according to study results.

Patients with obesity treated with endoscopic sleeve gastroplasty achieved durable results for at least 5 year after the procedure, according to study results.

The number of bariatric surgeries performed in the United States has increased with about 252000 surgeries performed annually.

Bariatric surgery can be an invaluable tool for managing the myriad complications of obesity such as diabetes, fatty liver disease, hypertension, hyperlipidemia, gastroesophageal reflux and obstructive sleep apnea.

Endoscopically placed intragastric balloons appeared to be safe and effective for the management of NASH, according to research published in Clinical Gastroenterology and Hepatology.